Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713748 · ClinicalTrials.gov registry record · NA
Tasso-SST OnDemand Comparator Pilot Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT04713748 is a NA study that has completed, run by Duke University. The registered enrollment target is 135 participants.
The verdict
NCT04713748, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
Purpose and objective: The purpose of this pilot study is participant user acceptance testing of the Tasso-SST OnDemand device to collect blood for antibody testing. The study will also compare antibody testing results from blood collected using the Tasso-SST OnDemand device compared to blood collected by phlebotomy. Study activities and population group: All participants enrolled in the MURDOCK C3PI Study (Pro Pro00105703), and actively participating in the testing cohort (n=300), will be emailed about the study. One or more reminder emails may be sent. The study seeks to enroll up to 100 participants. Participants will collect blood using the Tasso-SST OnDemand at the same visit where blood will be collected via phlebotomy for the MURDOCK C3PI study. Blood samples will be spun and processed for serum, which will be shipped frozen to analytical lab at Duke. Participants will complete a short survey about their experience using the Tasso-SST OnDemand device. Data analysis and risk/safety issues: The study team will evaluate correlation between results from blood collected by the two methods and qualitatively exam participant survey results. There are no risk/safety issues. Risk of reaction at the collection site is similar to that of phlebotomy and is described in the electronic consent form.
Interventions
- DEVICE Tasso-SST on Demand
- OTHER Regular Phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2021-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04713748
The ClinicalTrials.gov registry entry for NCT04713748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tasso-SST on Demand is the first listed.
NCT04713748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04713748 about?
NCT04713748 is a clinical study titled "Tasso-SST OnDemand Comparator Pilot Study". Purpose and objective: The purpose of this pilot study is participant user acceptance testing of the Tasso-SST OnDemand device to collect blood for antibody testing. The study will also compare antibody testing results from blood collected using the Tasso-SST OnDemand device compared to blood collec...
What is the current status of trial NCT04713748?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2021-01-15. Estimated completion is 2021-03-11.
What interventions are being tested in trial NCT04713748?
The interventions under investigation include: Tasso-SST on Demand (DEVICE), Regular Phlebotomy (OTHER).
Who is sponsoring clinical trial NCT04713748?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.